Founded in 1978, Biogen is a number one world-wide biotechnology corporation which has pioneered several breakthrough innovations together with a broad portfolio of medicines to take care of multiple sclerosis, the 1st authorized treatment for spinal muscular atrophy, two co-developed treatment options to deal with a defining pathology of Alzheimer